A novel prognostic risk score associated with resistance to docetaxel chemotherapy for predicting biochemical recurrence-free survival in patients with prostate cancer
We successfully identified a total of 67 docetaxel resistance related DEGs. A novel prognostic risk score associated with resistance to docetaxel chemotherapy of PCa was developed and validated, which performed well in predicting the BCRFS of PCa. High expression of NOG could promote the docetaxel resistance of PCa.
Authors
- Desheng Zhu (ORCID: https://orcid.org/0000-0003-2454-2173)
- Wentao Fan (ORCID: https://orcid.org/0000-0001-6694-7289)
- Ting Huang (ORCID: https://orcid.org/0000-0003-4370-8781)
- Hongbin Zhu (ORCID: https://orcid.org/0009-0003-1606-2978)
Institutions
- Quzhou City People's Hospital (CN)
- Guhua Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-16
- DOI
- https://doi.org/10.1007/s12672-025-03423-0
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jinhua Science and Technology Bureau